Cargando…
Circulating natural antibodies to inflammatory cytokines are potential biomarkers for atherosclerosis
BACKGROUND: Inflammatory cytokines contribute to the development of atherosclerosis. Natural antibodies in the circulation have protective effects on common diseases including atherosclerosis-related conditions. PURPOSE: The present study aimed to investigate the possible involvement of circulating...
Autores principales: | Wang, Peng, Zhao, Huan, Wang, Zhenqi, Zhang, Xuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240255/ https://www.ncbi.nlm.nih.gov/pubmed/30479572 http://dx.doi.org/10.1186/s12950-018-0199-2 |
Ejemplares similares
-
Altered levels of circulating natural antibodies against
VEGFR1-derived peptide in atherosclerosis
por: Wang, Peng, et al.
Publicado: (2020) -
Detection of circulating natural antibodies to inflammatory cytokines in type-2 diabetes and clinical significance
por: Cai, Weiyi, et al.
Publicado: (2017) -
Further analysis of natural antibodies against ischemic stroke
por: Qi, Jingjing, et al.
Publicado: (2023) -
Current advances in circulating inflammatory biomarkers in atherosclerosis and related cardio-cerebrovascular diseases
por: Lv, Jun-Xuan, et al.
Publicado: (2017) -
Anti-Inflammatory Therapy for Atherosclerosis: Focusing on Cytokines
por: Poznyak, Anastasia V., et al.
Publicado: (2021)